Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 September;58(3) > Panminerva Medica 2016 September;58(3):242-3

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2016 September;58(3):242-3

language: English

Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry

Andrea RUBBOLI 1, Cataldo PALMIERI 2, Giancarlo PIOVACCARI 3, Giuseppe DI PASQUALE 4, Carlo BRIGUORI 5, Massimo MARGHERI 6, for the WARfarin and coronary STENTing (WAR-STENT) Study Group

1 Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy; 2 Division of Cardiology, Ospedale del Cuore “G. Pasquinucci”, Massa, Italy; 3 Division of Cardiology, Ospedale degli Infermi, Rimini, Italy; 4 Division of Cardiology, Ospedale Maggiore, Bologna, Italy; 5 Department of Cardiology, Clinica Mediterranea, Napoli, Italy; 6 Department of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy


PDF  


top of page

Publication History

Cite this article as

Corresponding author e-mail

andrearubboli@libero.it.